angiotensin ii has been researched along with glucagon-like peptide 1 in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (11.11) | 18.2507 |
| 2000's | 3 (11.11) | 29.6817 |
| 2010's | 14 (51.85) | 24.3611 |
| 2020's | 7 (25.93) | 2.80 |
| Authors | Studies |
|---|---|
| Crews, EC; Gentry, RM; Rowland, NE | 1 |
| Larsen, PJ; Tang-Christensen, M; Vrang, N | 2 |
| Andreis, PG; Malendowicz, LK; Neri, G; Nussdorfer, GG; Tortorella, C | 1 |
| Bojanowska, E; Stempniak, B | 1 |
| Akimoto, Y; Kanai-Azuma, M; Kawakami, H; Ogawa, Y; Yanoshita, R | 1 |
| Cheng, Q; Leung, PS | 1 |
| Ishibashi, Y; Maeda, S; Matsui, T; Nakashima, S; Nishino, Y; Ojima, A; Yamagishi, S | 1 |
| Cahill, C; Geraldes, P; Hiraoka-Yamomoto, J; King, GL; Kitada, M; Li, C; Li, Q; Matsumoto, M; Mima, A; Mizutani, K; Nishikawa, S; Park, K; Rask-Madsen, C | 1 |
| Forster, K; Lutz, TA; Riediger, T; Züger, D | 1 |
| Fujimoto, K; Itoh, F; Koyama, T; Noguchi, Y; Sato, K; Shichiri, M; Watanabe, T | 1 |
| Ku, HC; Su, MJ | 1 |
| Chang, WH; Huang, CY; Lin, FY; Lu, HY; Shih, CC; Shih, CM; Tsai, CS | 1 |
| Bai, F; Li, XW; McKallip, RJ; Pang, XF; Shah, AI; Wang, NP; Wang, X; Zhang, LH; Zhao, ZQ | 1 |
| Hirano, T; Hiromura, M; Kohashi, K; Kushima, H; Mori, Y; Nagashima, M; Shinmura, K; Terasaki, M; Tomoyasu, M; Watanabe, T | 1 |
| Gribble, F; Larraufie, P; Pais, R; Reimann, F; Rievaj, J | 1 |
| Li, A; Qin, X; Zhang, M; Zhao, L; Zhou, T | 1 |
| Ding, W; Gu, Y; Guo, H; Li, H; Ling, L; Niu, J; Wang, B; Yang, M | 1 |
| Fan, SH; Li, XW; Niu, Y; Shi, YW; Xiong, QF; Zhang, LH; Zhang, X | 1 |
| Abouelkheir, M; El-Metwally, TH | 1 |
| Deguchi, H; Enzan, N; Ide, T; Ikeda, M; Ikeda, S; Ishikita, A; Matsushima, S; Okabe, K; Sada, M; Shinohara, K; Tadokoro, T; Tsutsui, H; Yamamoto, T | 1 |
| Asmar, A; Asmar, M; Bülow, J; Cramon, PK; Hartmann, B; Holst, JJ; Hovind, P; Jensen, BL; Madsbad, S; Moro, C; Rehfeld, JF; Simonsen, L; Sorensen, CM | 1 |
| Abouelkheir, M | 1 |
| Fan, S; Niu, Y; Qin, J; Shi, Y; Wang, J; Xiong, Q; Zhang, L; Zhang, X | 1 |
| Asmar, A; Christ-Crain, M; Jensen, BL; Sailer, CO; Vogt, DR; Vukajlovic, T; Winzeler, B | 1 |
| Bai, F; Banks, TE; Rajapaksha, M; Wang, NP; Zhang, LH; Zhao, ZQ | 1 |
| Andersen, UB; Asmar, A; Francis, S; Haddock, B; Jensen, BL; Kristensen, KB; Larsson, HBW; Lindberg, U; Tayyab, M; Vestergaard, M | 1 |
2 review(s) available for angiotensin ii and glucagon-like peptide 1
| Article | Year |
|---|---|
The novel roles of glucagon-like peptide-1, angiotensin II, and vitamin D in islet function.
Topics: Angiotensin II; Angiotensins; Animals; Blood Pressure; Cell Nucleus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucagon-Like Peptide 1; Humans; Islets of Langerhans; Mice; Models, Biological; Peptides; Vitamin D | 2010 |
Emerging roles for vasoactive peptides in diagnostic and therapeutic strategies against atherosclerotic cardiovascular diseases.
Topics: Adiponectin; Angiotensin II; Animals; Atherosclerosis; Biomarkers; Glucagon-Like Peptide 1; Humans; Intercellular Signaling Peptides and Proteins; Molecular Targeted Therapy; Neuregulin-1; Serotonin; Urotensins | 2013 |
3 trial(s) available for angiotensin ii and glucagon-like peptide 1
| Article | Year |
|---|---|
Increased oral sodium chloride intake in humans amplifies selectively postprandial GLP-1 but not GIP, CCK, and gastrin in plasma.
Topics: Adult; Aldosterone; Angiotensin II; Cholecystokinin; Gastric Inhibitory Polypeptide; Gastrins; Glucagon-Like Peptide 1; Humans; Intestines; Kidney; Male; Postprandial Period; Renin-Angiotensin System; Sodium Chloride, Dietary | 2020 |
Effect of a 3-Week Treatment with GLP-1 Receptor Agonists on Vasoactive Hormones in Euvolemic Participants.
Topics: Aldosterone; Angiotensin II; Diabetes Mellitus, Type 2; Double-Blind Method; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Immunoglobulin Fc Fragments; Natriuresis; Recombinant Fusion Proteins; Renin | 2022 |
GLP-1 Promotes Cortical and Medullary Perfusion in the Human Kidney and Maintains Renal Oxygenation During NaCl Loading.
Topics: Adult; Angiotensin II; Cross-Over Studies; Glucagon-Like Peptide 1; Humans; Kidney; Kidney Medulla; Male; Perfusion; Renal Circulation; Sodium Chloride; Young Adult | 2023 |
22 other study(ies) available for angiotensin ii and glucagon-like peptide 1
| Article | Year |
|---|---|
Comparison of Fos induced in rat brain by GLP-1 and amylin.
Topics: Amyloid; Angiotensin II; Animals; Bombesin; Brain; Cholecystokinin; Glucagon; Glucagon-Like Peptide 1; Islet Amyloid Polypeptide; Male; Oncogene Proteins v-fos; Peptide Fragments; Protein Precursors; Rats; Rats, Sprague-Dawley | 1997 |
Glucagon-like peptide 1(7-36) amide's central inhibition of feeding and peripheral inhibition of drinking are abolished by neonatal monosodium glutamate treatment.
Topics: Angiotensin II; Animals; Animals, Newborn; Arcuate Nucleus of Hypothalamus; Avoidance Learning; Blood Glucose; Blood-Brain Barrier; Brain; Cerebral Ventricles; Drinking; Eating; Food Additives; Food Deprivation; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Male; Neuropeptide Y; Peptide Fragments; Rats; Rats, Wistar; Sodium Glutamate; Subfornical Organ; Taste | 1998 |
Effects of glucagon and glucagon-like peptide-1 on glucocorticoid secretion of dispersed rat adrenocortical cells.
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Bucladesine; Colforsin; Corticosterone; Cyclic AMP; Glucagon; Glucagon-Like Peptide 1; Glucocorticoids; In Vitro Techniques; Male; Peptide Fragments; Protein Precursors; Rats; Rats, Sprague-Dawley; Steroids | 1999 |
Glucagon-like peptide containing pathways in the regulation of feeding behaviour.
Topics: Angiotensin II; Animals; Behavior, Animal; Drinking; Eating; Fasting; Glucagon; Glucagon-Like Peptide 1; Homeostasis; Male; Neuropeptide Y; Peptide Fragments; Protein Precursors; Rats | 2001 |
Mechanisms involved in glucagon-like peptide-1 (7-36) amide action on the rat hypothalamo-neurohypophysial system.
Topics: Analysis of Variance; Angiotensin II; Animals; Calcium; Colforsin; Cyclic AMP; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Hypothalamo-Hypophyseal System; Male; Neurotransmitter Agents; Organ Culture Techniques; Oxytocin; Peptide Fragments; Rats; Rats, Wistar; Second Messenger Systems; Vasopressins; Water-Electrolyte Balance | 2003 |
Exosome-like vesicles in Gloydius blomhoffii blomhoffii venom.
Topics: 5'-Nucleotidase; Actins; Amino Acid Sequence; Angiotensin II; Animals; Blood Pressure; Cholecystokinin; Chromatography, Gel; Crotalid Venoms; Dipeptidyl Peptidase 4; Electrophoresis, Polyacrylamide Gel; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Glutamyl Aminopeptidase; Homeostasis; Microscopy, Electron; Molecular Sequence Data; Protein Precursors; Secretory Vesicles; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Substance P; Viperidae | 2008 |
Glucagon-like peptide-1 inhibits angiotensin II-induced mesangial cell damage via protein kinase A.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Cyclic AMP-Dependent Protein Kinases; Diabetic Nephropathies; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Glucagon-Like Peptide 1; Hormones; Humans; Intercellular Adhesion Molecule-1; Isoquinolines; Mesangial Cells; NF-kappa B; Plasminogen Activator Inhibitor 1; RNA, Messenger; Sulfonamides; Up-Regulation | 2012 |
Protective effects of GLP-1 on glomerular endothelium and its inhibition by PKCβ activation in diabetes.
Topics: Angiotensin II; Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Endothelium; Exenatide; Gene Expression Regulation; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Hypoglycemic Agents; Kidney Glomerulus; Mice; Mice, Inbred C57BL; Mice, Transgenic; Peptides; Protein Kinase C; Protein Kinase C beta; Proto-Oncogene Proteins c-raf; Receptors, Glucagon; RNA Interference; Signal Transduction; Tissue Culture Techniques; Venoms | 2012 |
Amylin and GLP-1 target different populations of area postrema neurons that are both modulated by nutrient stimuli.
Topics: Amino Acids; Analysis of Variance; Angiotensin II; Animals; Area Postrema; Blood Glucose; Cell Count; Cross-Over Studies; Cyclic GMP; Dose-Response Relationship, Drug; Exenatide; Fasting; Feeding Behavior; Food; Gene Expression Regulation; Glucagon-Like Peptide 1; Islet Amyloid Polypeptide; Lithium Chloride; Male; Neurons; Peptides; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Receptors, Calcitonin; Time Factors; Venoms | 2013 |
DPP4 deficiency preserved cardiac function in abdominal aortic banding rats.
Topics: Angiotensin II; Animals; Aorta, Abdominal; Cardiomegaly; Collagen; Dipeptidyl Peptidase 4; Glucagon-Like Peptide 1; Heart Function Tests; Hemodynamics; Male; Pressure; Rats; Rats, Inbred F344; Signal Transduction; Up-Regulation | 2014 |
Dipeptidyl peptidase-4 inhibitor decreases abdominal aortic aneurysm formation through GLP-1-dependent monocytic activity in mice.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Apolipoproteins E; Apoptosis; Cell Movement; Cells, Cultured; Chemotaxis; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Drug Evaluation, Preclinical; Fibroblasts; Glucagon-Like Peptide 1; Humans; Infusion Pumps, Implantable; Macrophages; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Monocytes; Reactive Oxygen Species; Sitagliptin Phosphate; U937 Cells | 2015 |
Preservation of Glucagon-Like Peptide-1 Level Attenuates Angiotensin II-Induced Tissue Fibrosis by Altering AT1/AT 2 Receptor Expression and Angiotensin-Converting Enzyme 2 Activity in Rat Heart.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Collagen; Fibrosis; Gene Expression; Glucagon-Like Peptide 1; Linagliptin; Liraglutide; Male; Myocardium; Peptidyl-Dipeptidase A; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Smad Proteins; Transforming Growth Factor beta1 | 2015 |
A Dipeptidyl Peptidase-4 Inhibitor but not Incretins Suppresses Abdominal Aortic Aneurysms in Angiotensin II-Infused Apolipoprotein E-Null Mice.
Topics: Angiotensin II; Animals; Aorta; Aortic Aneurysm, Abdominal; Apolipoproteins E; Blood Pressure; Dipeptidyl-Peptidase IV Inhibitors; Gastric Inhibitory Polypeptide; Gene Expression Regulation; Glucagon-Like Peptide 1; Incretins; Inflammation; Interleukin-1beta; Male; Matrix Metalloproteinase 9; Mice; Mice, Knockout; Plaque, Atherosclerotic; Tissue Inhibitor of Metalloproteinase-2 | 2016 |
Angiotensin II Type 1 Receptor-Dependent GLP-1 and PYY Secretion in Mice and Humans.
Topics: Angiotensin II; Animals; Calcium Signaling; Colon; Enteroendocrine Cells; Female; Glucagon-Like Peptide 1; Humans; Intestinal Mucosa; Male; Mice, Inbred C57BL; Mice, Transgenic; Peptide YY; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Water-Electrolyte Balance | 2016 |
Activation of Nrf2 contributes to the protective effect of Exendin-4 against angiotensin II-induced vascular smooth muscle cell senescence.
Topics: Angiotensin II; Animals; Antioxidants; Cells, Cultured; Cellular Senescence; Exenatide; Glucagon-Like Peptide 1; Heme Oxygenase-1; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NADH, NADPH Oxidoreductases; NF-E2-Related Factor 2; Oxidation-Reduction; Oxidative Stress; Peptides; Protective Agents; Rats; Rats, Sprague-Dawley; Signal Transduction; Venoms | 2016 |
Protective Effects of Glucagon-Like Peptide-1 Analog on Renal Tubular Injury in Mice on High-Fat Diet.
Topics: Activating Transcription Factor 4; Angiotensin II; Animals; Blood Pressure; Body Weight; Diet, High-Fat; Eating; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Eukaryotic Initiation Factor-2; Gene Expression; Glucagon-Like Peptide 1; Heat-Shock Proteins; Kidney Tubules, Proximal; Male; Mice; Nephritis; Organ Size; Palmitic Acid; Protective Agents; Receptor, Angiotensin, Type 1; Transcription Factor CHOP | 2017 |
GLP-1 attenuates Ang II-induced proliferation and migration in rat aorta smooth muscle cells
Topics: Amides; Angiotensin II; Animals; Aorta; Cell Movement; Cell Proliferation; Cells, Cultured; Colforsin; Glucagon-Like Peptide 1; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphorylation; Pyridines; Rats; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction | 2018 |
Dipeptidyl peptidase-4 inhibitors can inhibit angiotensin converting enzyme.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Enalapril; Female; Glucagon-Like Peptide 1; Humans; Hypertension; Linagliptin; Peptidyl-Dipeptidase A; Protein Binding; Rats; Rats, Sprague-Dawley; Sitagliptin Phosphate | 2019 |
DPP (Dipeptidyl Peptidase)-4 Inhibitor Attenuates Ang II (Angiotensin II)-Induced Cardiac Hypertrophy via GLP (Glucagon-Like Peptide)-1-Dependent Suppression of Nox (Nicotinamide Adenine Dinucleotide Phosphate Oxidase) 4-HDAC (Histone Deacetylase) 4 Pathw
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Heart Rate; Histone Deacetylases; Mice; Myocytes, Cardiac; NADPH Oxidase 4; Oxidative Stress; Pyrazoles; Rats; Signal Transduction; Thiazolidines | 2020 |
Evaluation of Dual Inhibitory Effect of Anagliptin, Ramipril and Lisinopril on Angiotensin-Converting Enzyme and DPP-4 Activities.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Lisinopril; Pyrimidines; Ramipril; Rats; Rats, Sprague-Dawley | 2022 |
Glucagon-like peptide-1 attenuates cardiac hypertrophy via the AngII/AT1R/ACE2 and AMPK/mTOR/p70S6K pathways.
Topics: Adenylate Kinase; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Cardiomegaly; Cardiotonic Agents; Cell Line; Disease Models, Animal; Glucagon-Like Peptide 1; Hypertension; Liraglutide; Male; Morpholines; Myocytes, Cardiac; Piperidines; Rats; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; TOR Serine-Threonine Kinases; Triazines; Uracil | 2021 |
Suppression of angiotensin II-activated NOX4/NADPH oxidase and mitochondrial dysfunction by preserving glucagon-like peptide-1 attenuates myocardial fibrosis and hypertension.
Topics: Angiotensin II; Animals; Cardiomyopathies; Fibrosis; Glucagon-Like Peptide 1; Hypertension; Linagliptin; Liraglutide; Mitochondria; NADPH Oxidase 4; Rats; Rats, Sprague-Dawley | 2022 |